semaj83/ctmatch_classification huggingface dataset:
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 75.0-999.0,  Heart Failure Acute exacerbation of chronic heart failure Age over 75 Appropriate care supervision at home Telephone connection Living in the hospital-at-home catchment area and informed consent  Absence of family and social support Patients who need mechanical ventilation Severe dementia End-stage cancer History of severe renal impairment or hepatic failure with ascitis
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Heart Failure diagnosis of NYHA I, II or III heart failure (as identified by any of the following physical findings of heart failure (jugular venous distension, crackles, edema, S3); pulmonary edema on chest x-ray; BNP > 100 pg/ml; or at least two of the following symptoms: paroxysmal nocturnal dyspnea, shortness of breath, swelling, fatigue previous chemotherapy that contributed to the development of heart failure (i.e., heart failure develops or worsens after receiving chemotherapy, with no other obvious explanation) oriented to person, place, and time living in the Houston area (Harris county or a contiguous county), or planning to stay in the area for at least the next 16 weeks 18 years of age or older diagnosis of cancer have completed treatment, or are on long-term adjuvant or maintenance chemotherapy only  remain in NYHA class IV heart failure despite therapy have health problems or current treatments that would make exercise unsafe, as determined by the cardiologist cannot provide informed consent
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Congestive Heart Failure Male or female aged 18 or above Congestive Heart Failure with symptoms for more than 4 weeks before starting study Provision of informed consent  Current low blood pressure with symptoms Liver disease considered significant by the study doctor Pregnant or lactating females
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Right Sided Cardiac Failure Patients must have right sided failure secondary to right ventricular dysfunction, pulmonary hypertension, or tricuspid regurgitation Age greater than 18 years of age Right heart catheterization within the last year to rule out left-sided failure Evidence of fluid overload as indicated by 2 or more of the following: 1.) 2+ or more pitting edema of the lower extremities, 2.) scrotal or penile edema, 3.) JVP greater than or equal to 10 cm, 4.) abdominal ascites  Pulmonary capillary wedge pressure above 16 mmHg or history of elevated left ventricular filling pressures Serum creatinine > 2.0 Current use of an angiotensin I converting enzyme inhibitor or angiotensin receptor blocker will preclude participation in the RAS neurohormone portion of the study
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Heart Failure chronic stable heart failure  renal dysfunction or under treatment with antidiabetic agents
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 21.0-90.0,  Heart Failure Male or female patient's > 21 years of age with a severe congestive heart failure (New York Heart Association class III or IV) requiring an immediate administration of intravenous vasodilators drugs, oxygen therapy, and no less than 160 mg of intravenous furosemide were eligible for inclusion Definite evidence of underlying heart failure was also required as shown by at least two of the following a) Orthopnea on admission b) X-ray showing evidences of elevated wedge pressure indicating congestive heart failure c) recent prior hospitalization (within the 30 days prior to the index hospitalization) because a congestive heart failure episode d) echocardiography data showing a poor left ventricular ejection fraction (0.40 or lower measuring with the biplane Simpson's method e) non-invasive ventilation to the maintenance of SaO2 above 90% f) wet rales in at least the lower half of the lungs fields Patients with a final diagnosis of Congestive Heart Failure as a consequence of necrotic or chronic ischemic heart disease, or infective origin such as chronic Chagas Disease, chronic valvular heart disease (surgically repaired or not), and idiopathic origin were also included for the present study  Patients with a concomitant infective disease were excluded from the study Patients with evidence of evolving with multi organic failure (hepatic or renal dysfunction requiring dialysis), terminal disease, or any impeding cause of follow-up, including contraindications of vaccination, were excluded from the study Those with congestive heart failure following unstable coronary artery disease, or prior by-pass surgery, or angioplasty or congestive heart failure complicating myocardial infarction requiring urgent intervention were excluded also Those individuals who required mechanical ventilation on admission Patients with prior vaccinations were also excluded Pregnancy condition was an criterion Those patients who were unable or refused to give a written inform consent was also excluded of the present study
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 40.0-999.0,  Hypertension Self-identifies as African American Resides in Washington, DC or surrounding communities Has stage I hypertension, defined as systolic blood pressure between 140 and 159 mm Hg and/or diastolic blood pressure between 90 and 99 mm Hg, on average, without taking antihypertensive medications in the sympatholytic class (e.g., beta blockers, alpha antagonists, central nervous system agonists)  Blood pressure levels of less than 140/90 mm Hg or greater than 160/100 mm Hg History of clinical cardiovascular disease (e.g., heart attack, angina, intermittent claudication, congestive heart failure, stroke) Long-term kidney failure Any other life-threatening illness (e.g., advanced cancer) History of major psychiatric disorder (e.g., psychosis, dementia, substance abuse disorder)
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Hyperglycemia Obese African American subjects (BMI equal or greater than 30) age 18-65 patients with a history of diabetic ketoacidosis as defined by the ADA patients admitted with hyperglycemia but without ketoacidosis (BG greater than 400ml/dl without evidence of ketosis/ketones obese nondiabetic controls (BMI >30; ruled out for diabetes with a 75g oral glucose tolerance test)  patients with positive autoimmune markers [islet cell (ICA) or Glutamic acid decarboxylase (GAD) autoantibodies] patients with significant medical or surgical illness, including but not limited to myocardial ischemia, congestive heart failure, chronic renal insufficiency, liver failure, and infectious processes patients with recognized or suspected endocrine disorders associated with increased insulin resistance, such as hypercortisolism, acromegaly, or hyperthyroidism patients with bleeding disorders, thrombocytopenia, or abnormalities in coagulation studies patients with fasting hyperglycemia (blood glucose > 120 mg/dl) after discontinuation of insulin therapy, and 6) pregnancy
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 20.0-95.0,  Pulmonary Edema Patients in the intensive care unit using ventilator  Asthma, COPD, non-ventilated patients
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Heart Failure Patients with stable congestive heart failure on a prescription for diuretic drugs  Acute heart failure Foreseeable need for further changes in medication Current medication containing vitamins Patients with a creatinine above 250 μmol/l
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Congestive Heart Failure subjects will be at least 50 years of age women who are post-menopausal clinical evidence of congestive heart failure, with ongoing management by conventional medical therapy a left ventricular ejection fraction below 40% as measured by echocardiogram performed within 6 months of study enrollment Left ventricular end-diastolic dimension greater than 60 mm as measured by an echocardiogram performed within 6 months of study enrollment regular heart rate/pacer hemodynamically stable and able to complete symptom-limited bicycle ergometry exercise test and be in New York Heart Association Classification II or III  Subjects with hematocrit equal to or less than 33% body mass index equal to or greater than 40 unstable angina within six months inducible ischemia by exercise stress testing, radionuclide scintigraphy, or dobutamine echocardiography known or suspected myocarditis known or suspected restrictive or infiltrative cardiomyopathy coronary artery stenosis >70% and < 100% by catheterization should such data be available inadequate cardiac echo window primary diastolic dysfunction in heart failure inability to perform cycle ergometry
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Congestive Heart Failure Hypovitaminosis D Hypomagnesemia Hyperparathyroidism congestive heart failure  pregnant hospitalized within one month taking calcium, vitamin D or magnesium supplements proteinuria > 1g/24h creatinine clearance <35 (MDRD)
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Heart Failure Patients with documented heart failure (NYHA class II-IV)  Use of both ACEi and ARB, ACEi and DRI, ARB and DRI treatment, or all three medications at Screening
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Congestive Heart Failure Subject eligible for implantation of a CRT-D device according to current available guidelines for cardiac resynchronization therapy Subject has severe heart failure (NYHA Class III or IV) Subject has experienced at least one heart failure event within six months prior to enrollment Subject continues to have heart failure symptoms despite receiving optimal medical therapy Schedule for implant of a CRT-D (Model 8770) Subject has signed and dated an informed consent form  Any contraindication for standard cardiac pacing Any contraindication for ICD therapy Abdominal implantation site Hypertrophic or obstructive cardiomyopathy Acute myocarditis Unstable coronary symptoms (unstable angina or myocardial infarction) within the last month Recent (within the last month) or planned cardiac revascularization or coronary angioplasty Correctable valvular disease that is the primary cause of heart failure Mechanical tricuspid valve Receiving continuous intra-venous infusion of positive inotropic therapy or intermittent therapy (intravenous infusion) more than twice per week
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Heart Failure Normal subject without history, signs-symptoms or diagnosis of heart failure Age over 18 and willing and able to provide informed consent  Known allergy to electrode gel and medical adhesive used on electrocardiographic electrodes Pregnancy (as any effect of this device use on pregnancy is not known) Patient belonging to a vulnerable population such as institutionalized persons, prisoners and persons with decisional incapacity or dementia Presence of severe aortic regurgitation Second degree Mobitz type II or third degree heart block, unless treated with a cardiac pacemaker Implantation of a left ventricular assists device, hemodynamic monitor, activated minute ventilation pacemaker, or biventricular pacemaker (Cardiac Resynchronization Therapy) with the V-to-V interval set at more than 5 milliseconds offset Implantation of a cardiac resynchronization device within the last 30 days HEART Patients over the age of 18 and able to give consent Ability to understand and willing to sign informed consent
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Sleep Apnea, Central Men and women 18 to 79 years of age who have New York Heart Association (NYHA) functional class I through IV heart failure due to ischemic, hypertensive, or idiopathic dilated cardiomyopathy and whose condition had been stabilized by means of optimal medical therapy for at least one month An LVEF of less than 40% and central sleep apnea, defined as 15 or more episodes of apnea and hypopnea per hour of sleep, more than 50 percent of which are determined to be central rather than obstructive  Pregnancy Myocardial infarction Unstable angina or cardiac surgery within the previous three months
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Hypertension currently taking an ACEi, ARB or both no change in these medications during the two weeks prior to study enrollment scheduled for non-cardiac surgery requiring regional or general anesthesia minimum overnight anticipated length of stay age ≥18 years  explicit instructions provided to patient by surgical team regarding the perioperative management of ACEi or ARB significant hypertension in pre-operative assessment clinic (systolic blood pressure ≥180 mmHg OR diastolic blood pressure ≥110 mmHg) significant hypotension in pre-operative assessment clinic (systolic blood pressure < 90 mmHg) prior enrollment in the study participation in another research study of antihypertensive medications
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Heart Failure Age greater than or equal to 60 years of age Symptoms of congestive heart failure Able to understand and give informed consent  Age <60 years Does not have CHF Significant change in cardiac medication <3 weeks Myocardial infarction <3 weeks CABG surgery <3 months Angina pectoris not controlled during daily activity by pharmacological therapy or at <4 METS activity Sustained hypertension with systolic> 190 and diastolic> 110 on medications Valvular heart disease as the primary etiology of CHF Significant aortic stenosis Stroke of <3 months or with any physical restriction impairment that would prevent participation in exercise programs
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Decompensated Heart Failure >18 years old Severe systolic heart failure with ejection fraction <40% And Hospitalisation for decompensated heart failure And New York Heart Association (NYHA) III or IV And 1 of the following Jugular vein distension>6cm Tissue Doppler mitral annulus lateral>12 or medial>15 Chest X-ray: pulmonary edema or pleural effusion  Need for inotropic or vasopressive agents Use of intravenous (IV) contrast media Acute coronary syndrome Need of dialysis Severe co-morbidity Contra-indications for anticoagulation Pregnancy
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Heart Failure hospitalized with admitting diagnosis of heart failure in prior 8 weeks self-identified as African American community-dwelling (i.e., not in a long-term care facility) residence within a predefined radius in Baltimore City working telephone in their home provide signed informed consent  cannot speak or understand English severe renal insufficiency requiring dialysis acute myocardial infarction within preceding 30 days receiving home care services for HF post discharge legally blind or have major hearing loss screen positive for cognitive impairment on the Mini-cog at baseline unable to stand independently on a weight scale (limited ability to participate in HAT system) weigh more than 325 pounds (exceed scale capacity) serious or terminal condition such as psychosis or cancer (actively receiving chemo or radiation) pregnant
Patient description: A 65 yo African-American male with shortness of breath related to exertion that has been worsening over the past three weeks. He also has difficulty breathing when lying flat and has started using two to three extra pillows at night. Significant physical exam findings include bibasilar lung crackles, pitting ankle edema and jugular venous distension.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Heart Failure Chronic Obstructive Pulmonary Disease patients aged 65 years and older must have a minimum of three chronic or vitality threatening diseases and/or use five or more medical drugs chronically in the last year must have dyspnea and/or reduced exercise tolerance (scored by two short questionnaires)  patients with both confirmed COPD and heart failure (Spirometry performed < 1 year ago and heart failure confirmed by echocardiography) patients unable or unwilling to sign informed consent